Latham Represents Blackstone Credit & Insurance in US$1.3 Billion Financing to Support Combination of Paratek Pharmaceuticals and Radius Health

Blackstone Credit & Insurance (BXCI) has announced that it is leading a US$1.3 billion financing in support of the combination of Paratek Pharmaceuticals and Radius Health that creates a scaled, multi‑asset specialty pharmaceutical company.

Latham & Watkins LLP represented BXCI in the financing with a team led by partners Stelios Saffos, Haim Zaltzman, Peter Sluka, and Michael Waldman, and counsel Benjamin Gelfand, with associate Youn Song. Advice was also provided on healthcare and life sciences matters by partner Todd Trattner, with associate Dylan O’Connor; on healthcare regulatory matters by partner Betty Pang; on FDA regulatory matters by partner Elizabeth Richards, with associate Evan Miller; and on tax matters by partner Bora Bozkurt, with associate Joyce Shin.